Last Gasp Or New Life? 2009's Novel Products Have Blockbuster Potential
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
After a 2008 NME approval slate that was heavy on modest specialty products, the 2009 user fee calendar offers a possible a return of the blockbuster.